Redhill Biopharma
开盘价
市值
最高价
最低价
收盘价
成交量
市盈率
股息率
Redhill Biopharma简介
雷德希尔生物制药有限公司开发治疗胃肠道和传染病的药物。它通过商业运营和研发部门进行运营。商业运营部门涵盖与商业销售相关的所有领域，由该子公司在美国执行。研究和开发部门包括候选治疗药物的研究和许可。其产品包括Talicia、Movantik和Aemcolo。该公司由Dror Ben-Asher和Ori Shilo于2009年8月3日创立，总部设在以色列特拉维夫。
如何购买 Redhill Biopharma (RDHL)
登录
1分钟开户
仅需1分钟即可完成账户申请和验证。整个过程完全自助，支持 RockFlow App 和网页端操作。
充值资金
账户验证完成后，您可以使用首选的支付方式向账户充值。
购买 RDHL
通过 RockFlow App 或网页端搜索 RDHL，输入您想要投资的金额，然后点击确认即可完成交易。
© Rockalpha Limited. All Rights Reserved.
Rockalpha Limited is registered on the New Zealand Financial Service Providers Register(FSP: 1001454). Rockalpha Limited's Financial Service Providers registration can be verified on the Financial Service Providers Register. Rockalpha Limited is a member of the Insurance & Financial Services Ombudsman Scheme, an independent dispute resolution service provider. Rockalpha Limited is not licensed by a New Zealand regulator to provide the client money or property services, and Rockalpha Limited’s registration on the New Zealand register of financial service providers or membership of the Insurance & Financial Services Ombudsman Scheme does not mean that Rockalpha Limited is subject to active regulation or oversight by a New Zealand regulator.Rockalpha Limited is registered on the New Zealand Financial Service Providers Register(FSP: 1001454). Rockalpha Limited's Financial Service Providers registration can be verified on the Financial Service Providers Register. Rockalpha Limited is a member of the Insurance & Financial Services Ombudsman Scheme, an independent dispute resolution service provider.